About

Our mission & values
We are on a mission to harness the microbiome to transform the lives of patients. To achieve our mission, we have assembled a team of multi-disciplinary experts and built a culture that values collaboration and a diversity of perspectives and ideas. Our team is united by our collective desire to develop a novel class of therapeutics for patients and families battling serious conditions linked to disruption of the microbiome.
Built into our company DNA is a strong commitment to living our core values and utilizing them to guide our decisions and actions.
Patients first
We have an unwavering commitment to putting the needs of patients first in everything we do
Tenacity
We work relentlessly to achieve our mission and deliver on our commitments
Humility
We maintain open minds and constantly work to expand our knowledge
Daring
We push scientific boundaries and ourselves
Community
We are committed to nurturing a strong, diverse community within Finch and giving back to the external communities we are a part of
Our leadership team
Our leadership team is comprised of seasoned biotech executives and recognized leaders in the microbiome field—clinicians and scientists that have paved the way for a new class of therapeutics with the potential to treat a wide range of conditions linked to disruption of the microbiome. Our leadership team combines decades of experience in the areas of microbiology, data science, clinical research, and the manufacture and commercialization of complex biologics.

Mark Smith, PhD
Chief Executive Officer

Marc Blaustein
Chief Operating Officer

Alka Batycky, PhD
Chief Development Officer

Howard Franklin, MD, MBA
Chief Medical Officer

Bryan Gillis, MBA
Chief Technology Officer